Silencing of ABCG2 gene expression in HCT15 colon cells using the CRISPR-Cas9 technique in an in vitro gout model

Authors

  • JESUS FABIAN CERVANTES MENESES UNAM https://orcid.org/0000-0003-1923-2314
  • Rosy Yunuen Velázquez Jimenez QFB, FES Zaragoza, MEXICO
  • Javier Fernández Torres Laboratorio de Líquido Sinovial, INR, MEXICO
  • Yessica Eduviges Zamudio Cuevas Laboratorio de Líquido Sinovial, INR, MEXICO
  • Karina Martínez Flores Laboratorio de Liquido Sinovial, INR, MEXICO
  • Ámbar López Macay Laboratorio de Líquido o Sinovial, INR, MEXICO

Keywords:

CRISPR-Cas9, Gout, MSU, ABCG2, HCT15

References

No aplica

Published

2024-10-26

How to Cite

1.
CERVANTES MENESES JF, Velázquez Jimenez RY, Fernández Torres J, Zamudio Cuevas YE, Martínez Flores K, López Macay Ámbar. Silencing of ABCG2 gene expression in HCT15 colon cells using the CRISPR-Cas9 technique in an in vitro gout model. Invest. Discapacidad [Internet]. 2024 Oct. 26 [cited 2024 Dec. 22];10(S2):e02. Available from: http://dsm.inr.gob.mx/indiscap/index.php/INDISCAP/article/view/196

Most read articles by the same author(s)

Similar Articles

You may also start an advanced similarity search for this article.